According to the IHME report, the novel Omicron subvariant XBB, which is causing an increase in hospitalizations in Singapore, is more transmissible but less harmful.
The Institute for Health Metrics and Evaluation (IHME) has said that the death rate is not anticipated to increase as a result of the rise in COVID 19 infections.
The University of Washington said in an analysis that global COVID-19 infections are projected to increase gradually to an average daily cases of about 18.7 million by February next year, from the current 16.7 million daily, driven by the northern hemisphere's winter months . The University of Washington's Institute for Health Metrics and Evaluation (IHME) said the increase in infections is not expected to lead to an increase in deaths. It estimates the global daily death toll on February 1 will average 2,748, compared to around 1,660 now.
IHME estimates that daily infections in the United States will rise by a third to more than one million, driven by seasonal illness related to students returning to school and cold weather.
A surge is already peaking in Germany, it said in its report on October 24, and expects cases to drop by more than a third to about 190,000 by February.
The IHME report suggests that the current surge in COVID-19 infections in Germany may be due to the Omicron subvariant BQ.1 or BQ.1.1, and is likely to spread to other parts of Europe in the coming weeks.
The rapid increase in hospitalizations in Germany - the highest since the COVID outbreak in 2020 - remains a matter of concern, the report said.
IHME's analysis also suggests that the new Omicron subvariant XBB, which is currently causing increased hospitalizations in Singapore, is more transmissible but less severe.
The global impact of XBB is expected to be silenced by the fact that people who were previously infected with Omicron's BA.5 subvariant are likely to have immunity to it, the report suggests.
No comments:
Post a Comment